Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03988166 · ClinicalTrials.gov registry record · NA

Chronic Total Occlusion Percutaneous Coronary Intervention Study

A NA study of Ischemic Heart Disease and Chronic Total Occlusion of Coronary Artery, sponsored by Vascular Solutions.

Completed
Registry status
NA
Development phase
150
Enrollment target
13
Study locations

NCT03988166 is a NA study of Ischemic Heart Disease and Chronic Total Occlusion of Coronary Artery that has completed, run by Vascular Solutions. The registered enrollment target is 150 participants, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower). The trial reports 13 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03988166, a NA study of Ischemic Heart Disease and Chronic Total Occlusion of Coronary Artery, has completed, sponsored by Vascular Solutions.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
13
Study locations

Study Summary

The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

Conditions Studied

Ischemic Heart Disease Chronic Total Occlusion of Coronary Artery Chronic Total Occlusion

Interventions

  • PROCEDURE Chronic Total Occlusion Revascularization
  • DEVICE GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter

Study Locations (13)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Massachusetts General Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University - Atlanta

New York

  • NYU Langone Health - New York
  • Columbia University Medical Center - New York

California

  • Torrance Memorial Medical Center - Torrance

Michigan

  • Henry Ford Hospital - Detroit

Minnesota

  • Minneapolis Heart Institute Foundation - Minneapolis

Missouri

  • Missouri Cardiovascular Specialists - Columbia

Ohio

  • The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2020-05-20
Est. Completion 2021-02-22
Phase NA

Sponsor

Vascular Solutions

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03988166

The ClinicalTrials.gov registry entry for NCT03988166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower). The listed sponsor is Vascular Solutions, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ischemic Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Chronic Total Occlusion Revascularization is the first listed.

NCT03988166 reports 13 study locations spanning 9 distinct geographic areas - top geographies include Massachusetts, Georgia, New York.

Frequently Asked Questions

What is clinical trial NCT03988166 about?

NCT03988166 is a clinical study titled "Chronic Total Occlusion Percutaneous Coronary Intervention Study". The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

What is the current status of trial NCT03988166?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-05-20. Estimated completion is 2021-02-22.

What conditions does trial NCT03988166 study?

This clinical trial studies the following conditions: Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery, Chronic Total Occlusion.

What interventions are being tested in trial NCT03988166?

The interventions under investigation include: Chronic Total Occlusion Revascularization (PROCEDURE), GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter (DEVICE).

Who is sponsoring clinical trial NCT03988166?

This trial is sponsored by Vascular Solutions, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03988166 being conducted?

This trial has 13 study locations across California, Georgia, Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Heart Disease

All registered trials for this condition

Chronic Total Occlusion of Coronary Artery

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.